Blood
Withaferin A inhibits EBV-driven lymphomagenesis through multiple mechanisms, including EBNA1 degradation.
Jessica Stewart, Blossom Damania
Published: 202510.1182/blood.2025029771
Abstract
Epstein-Barr virus (EBV) infects over 90% of the global population and drives multiple aggressive B cell malignancies, including Burkitt lymphoma (BL), diffuse large B cell lymphoma (DLBCL), and Hodgkin lymphoma. Standard chemoimmunotherapy regimens…
Preview only. Read the full abstract at the source